Efficiency of torasemide in heart failure in patients with ischemic heart disease and chronic obstructive pulmonary disease
| dc.contributor.author | Knyazkova, Iryna | |
| dc.contributor.author | Bilovol, Olexandr | |
| dc.contributor.author | Tsygankov, A. | |
| dc.date.accessioned | 2015-09-02T12:26:01Z | |
| dc.date.available | 2015-09-02T12:26:01Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | The 16-week therapy with torasemide in patients with CHF associated with IHD and COPD is accompanied by improvement of systolic and diastolic left ventricular function, reducing sizes of the left and right chambers of the heart, decrease in pulmonary artery pressure and has no effect on lung function, along with the safety and well tolerance. | ru_RU |
| dc.identifier.citation | Knyazkova I. I. Efficiency of torasemide in heart failure in patients with ischemic heart disease and chronic obstructive pulmonary disease : Special Issue : Abstracts of the Heart Failure 2015 and the 2nd World Congress on Acute Heart Failure, Seville, Spain, 23–26th May 2015 / I. I. Knyazkova, A. N. Bilovol, A. I. Tsygankov // European Journal of Heart Failure. – 2015. – Vol. 17, Suppl. 1. – P. 337. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/9438 | |
| dc.language.iso | en | ru_RU |
| dc.subject | torasemide | ru_RU |
| dc.subject | ischemic heart disease | ru_RU |
| dc.subject | chronic obstructive pulmonary disease | ru_RU |
| dc.subject | treatment | ru_RU |
| dc.title | Efficiency of torasemide in heart failure in patients with ischemic heart disease and chronic obstructive pulmonary disease | ru_RU |
| dc.type | Thesis | ru_RU |